177 related articles for article (PubMed ID: 36899930)
21. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
Turanli B; Gulfidan G; Arga KY
OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
[TBL] [Abstract][Full Text] [Related]
22. Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target.
Islam S; Wang S; Bowden N; Martin J; Head R
Br J Clin Pharmacol; 2022 Jan; 88(1):64-74. PubMed ID: 34192364
[TBL] [Abstract][Full Text] [Related]
23. Computationally repurposing drugs for breast cancer subtypes using a network-based approach.
Firoozbakht F; Rezaeian I; Rueda L; Ngom A
BMC Bioinformatics; 2022 Apr; 23(1):143. PubMed ID: 35443626
[TBL] [Abstract][Full Text] [Related]
24. Repurposing of antipsychotics perphenazine for the treatment of endometrial cancer.
Chen Y; Cui Y; Sun X; Wu H; Ou M; Tang Y; Ni S; Li X; Zhu J; Mao F; Wang Y; Li J
Bioorg Med Chem Lett; 2020 Jul; 30(14):127239. PubMed ID: 32527541
[TBL] [Abstract][Full Text] [Related]
25. Identification of early stage recurrence endometrial cancer biomarkers using bioinformatics tools.
Besso MJ; Montivero L; Lacunza E; Argibay MC; Abba M; Furlong LI; Colas E; Gil-Moreno A; Reventos J; Bello R; Vazquez-Levin MH
Oncol Rep; 2020 Sep; 44(3):873-886. PubMed ID: 32705231
[TBL] [Abstract][Full Text] [Related]
26. Network-Based Approaches Reveal Potential Therapeutic Targets for Host-Directed Antileishmanial Therapy Driving Drug Repurposing.
Martinez-Hernandez JE; Hammoud Z; de Sousa AM; Kramer F; Monte-Neto RLD; Maracaja-Coutinho V; Martin AJM
Microbiol Spectr; 2021 Oct; 9(2):e0101821. PubMed ID: 34668739
[No Abstract] [Full Text] [Related]
27. Validation of transcriptome signature reversion for drug repurposing in oncology.
Koudijs KKM; Böhringer S; Guchelaar HJ
Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36445193
[TBL] [Abstract][Full Text] [Related]
28. An Analytical Review of Computational Drug Repurposing.
Sadeghi SS; Keyvanpour MR
IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(2):472-488. PubMed ID: 31403439
[TBL] [Abstract][Full Text] [Related]
29. Integrative microRNA and gene expression analysis identifies new drug repurposing candidates for fetal hemoglobin induction in β-hemoglobinopathies.
Das SS; Sinha R; Chakravorty N
Gene; 2019 Jul; 706():77-83. PubMed ID: 31048070
[TBL] [Abstract][Full Text] [Related]
30. REPRODUCIBLE DRUG REPURPOSING: WHEN SIMILARITY DOES NOT SUFFICE.
Guney E
Pac Symp Biocomput; 2017; 22():132-143. PubMed ID: 27896969
[TBL] [Abstract][Full Text] [Related]
31. Integrating gene expression and clinical data to identify drug repurposing candidates for hyperlipidemia and hypertension.
Wu P; Feng Q; Kerchberger VE; Nelson SD; Chen Q; Li B; Edwards TL; Cox NJ; Phillips EJ; Stein CM; Roden DM; Denny JC; Wei WQ
Nat Commun; 2022 Jan; 13(1):46. PubMed ID: 35013250
[TBL] [Abstract][Full Text] [Related]
32. Drug Repurposing for Cancer Therapy in the Era of Precision Medicine.
K W To K; Cho WCS
Curr Mol Pharmacol; 2022; 15(7):895-903. PubMed ID: 35156588
[TBL] [Abstract][Full Text] [Related]
33. Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival.
Mauland KK; Wik E; Hoivik EA; Kusonmano K; Halle MK; Berg A; Haugland HK; Øyan AM; Kalland KH; Stefansson IM; Akslen LA; Krakstad C; Trovik J; Werner HM; Salvesen HB
Oncotarget; 2017 Feb; 8(6):9696-9707. PubMed ID: 28039471
[TBL] [Abstract][Full Text] [Related]
34. A machine learning and network framework to discover new indications for small molecules.
Gilvary C; Elkhader J; Madhukar N; Henchcliffe C; Goncalves MD; Elemento O
PLoS Comput Biol; 2020 Aug; 16(8):e1008098. PubMed ID: 32764756
[TBL] [Abstract][Full Text] [Related]
35. Multiomics profiling of the expression and prognosis of MCMs in endometrial carcinoma.
Lan H; Yuan J; Chen X; Liu C; Guo X; Wang X; Song J; Cao K; Xiao S
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34859821
[TBL] [Abstract][Full Text] [Related]
36. Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer.
Alonso-Alconada L; Muinelo-Romay L; Madissoo K; Diaz-Lopez A; Krakstad C; Trovik J; Wik E; Hapangama D; Coenegrachts L; Cano A; Gil-Moreno A; Chiva L; Cueva J; Vieito M; Ortega E; Mariscal J; Colas E; Castellvi J; Cusido M; Dolcet X; Nijman HW; Bosse T; Green JA; Romano A; Reventos J; Lopez-Lopez R; Salvesen HB; Amant F; Matias-Guiu X; Moreno-Bueno G; Abal M;
Mol Cancer; 2014 Sep; 13():223. PubMed ID: 25261936
[TBL] [Abstract][Full Text] [Related]
37. Repurposing drugs in oncology: From candidate selection to clinical adoption.
Pantziarka P; Verbaanderd C; Huys I; Bouche G; Meheus L
Semin Cancer Biol; 2021 Jan; 68():186-191. PubMed ID: 31982510
[TBL] [Abstract][Full Text] [Related]
38. Artificial intelligence, machine learning, and drug repurposing in cancer.
Tanoli Z; Vähä-Koskela M; Aittokallio T
Expert Opin Drug Discov; 2021 Sep; 16(9):977-989. PubMed ID: 33543671
[No Abstract] [Full Text] [Related]
39. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
Mottini C; Napolitano F; Li Z; Gao X; Cardone L
Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
[TBL] [Abstract][Full Text] [Related]
40. Repurposing Drugs for Skin Cancer.
Khachigian LM
Curr Med Chem; 2020; 27(42):7214-7221. PubMed ID: 31858902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
